BiVictriX Therapeutics plc Shares now trading on JP Jenkins
11th Sept 2024 JPJ: BVX ISIN: GB00BNXH3K91 BiVictriX Therapeutics plc (“BiVictriX” or the “Company”) Shares now trading on JP Jenkins London, UK. 11th Sept July 2024 – BiVictriX Therapeutics plc (JPJ: BVX), a drug discovery and development company applying an innovative, proprietary approach to develop a new class of highly selective, next generation cancer therapeutics, bispecific […]
Interim Results for the Six Months Ended 30 June 2024
Released : 01/08/2024 07:00 RNS Number : 6863Y BiVictriX Therapeutics PLC 01 August 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, […]
Proposed voluntary cancellation of admission of Ordinary Shares to trading on AIM
RNS Number : 9863Z BiVictriX Therapeutics PLC 12 August 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information […]
